SPIROCHETES
SPIROCHETES
Treponema pallidum
• "Treponema" combines Greek "trepo" (to turn) and "nema" (thread), referring to its spiral shape.
• "Pallidum" from Latin means "pale," describing its microscopic appearance.
CULTURE
• Limitations: Pathogenic T. pallidum has never been successfully cultured in artificial media,
fertile eggs, or tissue culture.
• Viability: Remains motile for 3–6 days at 25°C in suitable fluids; viable for at least 24 hours in
whole blood or plasma at 4°C.
GENOME
• Size and Structure: Circular chromosome of approximately 1,138,000 base pairs, relatively small
for bacteria.
• Characteristics: Lack of transposable elements suggests a highly conserved genome; reliant on
host for energy production and nutrient synthesis.
ANTIGENIC STRUCTURE
• Limited Characterization: Due to inability to culture in vitro.
• Outer Membrane: Contains proteins with covalently bound lipids, inaccessible to antibodies.
• Endoflagella: Contain core proteins and a sheath protein, play a role in organism's invasiveness.
• Enzymes: Hyaluronidase breaks down hyaluronic acid in tissues.
• Enzymes: Hyaluronidase breaks down hyaluronic acid in tissues.
IMMUNITY
• Resistance: Individuals with active or latent syphilis show resistance to superinfection with T.
pallidum.
• Post-Treatment Susceptibility: After effective treatment of early syphilis, susceptibility to the
infection is restored.
• Limitation: Immune responses generally fail to eradicate the infection or halt its progression.
TREATMENT
• Penicillin: Primary treatment with significant treponemicidal activity.
• Follow-Up: Essential, especially in neurosyphilis and patients with AIDS.
• Jarisch-Herxheimer Reaction: May occur after starting treatment due to toxin release from dying
spirochetes.
• Dosage and Administration:
o Early Syphilis: Single injection of benzathine penicillin G (2.4 million units IM).
o Older/Latent Syphilis: Benzathine penicillin G IM, three doses at weekly intervals.
o Neurosyphilis: Same therapy or higher doses of intravenous penicillin; alternative antibiotics like
tetracyclines or erythromycin possible.
EPIDEMIOLOGY, PREVENTION, AND CONTROL
• Transmission: Mainly through sexual contact; congenital syphilis and occupational exposures are
rare.
• Contagious Period: 3–5 years during early syphilis; late syphilis (over 5 years) usually non-
contagious.
• Control Measures: Prompt treatment of cases, follow-up on contacts, safe sex practices
(condoms), and consideration of syphilis in diagnoses of other sexually transmitted diseases.
Treponema pallidum
ACQUIRED SYPHILIS
• Transmission: Primarily through sexual contact, with infectious lesions on skin or mucous
membranes. Non-genital lesions occur in 10-20% of cases.
• Infection Entry: Via intact mucous membranes or breaks in the epidermis.
• Early Development: Spirochetes multiply locally, spread to lymph nodes, then bloodstream.
Primary Stage: Papule formation at infection site, evolving into a hard-based ulcer (“hard
chancre”), healing spontaneously.
Secondary Stage: Occurs 2-10 weeks later, presenting red maculopapular rash, condylomas, and
possible syphilitic meningitis, hepatitis, or nephritis. Lesions subside but are highly infectious.
Tertiary Stage: In about 30% of untreated cases, characterized by granulomatous lesions
(gummas), CNS degeneration (meningovascular syphilis, paresis, tabes), or cardiovascular lesions.
Treponemes rare in these lesions.